The startup operates an AI-supported platform for cancer diagnosis and treatment, providing tailored patient packages that include clinical AI reports and secure video consultations with oncologists, radiologists, and surgeons. This platform enables healthcare insurers and overseas cancer clinics to make informed decisions on treatment plans, medication, and clinical trials, addressing the need for personalized and efficient cancer care.
Funding
$350K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare insurers and overseas cancer clinics face challenges in making informed decisions on treatment plans, medication, and clinical trials due to the complexity and variability of cancer cases. Traditional cancer diagnosis and treatment planning often lack personalization and efficiency, leading to suboptimal outcomes.
Solution
Docnoc.health offers an AI-supported platform designed to enhance cancer diagnosis and treatment. The platform provides tailored patient packages that include clinical AI reports, offering insights to guide treatment decisions. Secure video consultations with oncologists, radiologists, and surgeons are also facilitated, enabling collaborative and informed decision-making. This integrated approach aims to provide personalized and efficient cancer care, ultimately improving patient outcomes.
Target Audience
The primary customers are healthcare insurers and overseas cancer clinics seeking to improve the efficiency and personalization of cancer care.
Features
- AI-powered clinical reports for personalized cancer diagnosis
- Secure video consultations with oncology specialists